Clinical Trial Update: A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy [Phase 2]

View source ↗

Summary

PVX108 is being studied in a Phase 2 safety and efficacy trial for peanut allergy in children and adolescents, with the study currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy
• Peanut-induced Anaphylaxis

Drugs mentioned

• PVX108

Snippet

Sponsor: Aravax Pty Ltd | Conditions: Peanut Allergy, Peanut Hypersensitivity | Phase 2 | Status: ACTIVE_NOT_RECRUITING